Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

SHA:600594 Statistics

Total Valuation

SHA:600594 has a market cap or net worth of CNY 3.15 billion. The enterprise value is 3.54 billion.

Market Cap	3.15B
Enterprise Value	3.54B

Important Dates

The next estimated earnings date is Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:600594 has 784.39 million shares outstanding. The number of shares has decreased by -0.39% in one year.

Current Share Class	784.39M
Shares Outstanding	784.39M
Shares Change (YoY)	-0.39%
Shares Change (QoQ)	-5.11%
Owned by Insiders (%)	24.65%
Owned by Institutions (%)	0.24%
Float	574.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.65
PB Ratio	1.25
P/TBV Ratio	1.61
P/FCF Ratio	74.42
P/OCF Ratio	34.70
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-15.08
EV / Sales	1.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	83.49

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.34.

Current Ratio	1.88
Quick Ratio	1.16
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	20.44
Interest Coverage	-8.41

Financial Efficiency

Return on equity (ROE) is -9.49% and return on invested capital (ROIC) is -6.72%.

Return on Equity (ROE)	-9.49%
Return on Assets (ROA)	-2.96%
Return on Invested Capital (ROIC)	-6.72%
Return on Capital Employed (ROCE)	-6.38%
Weighted Average Cost of Capital (WACC)	5.05%
Revenue Per Employee	362,459
Profits Per Employee	-44,597
Employee Count	5,261
Asset Turnover	0.48
Inventory Turnover	1.42

Taxes

Income Tax	-708,948
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.47% in the last 52 weeks. The beta is 0.29, so SHA:600594's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	+19.47%
50-Day Moving Average	4.14
200-Day Moving Average	4.11
Relative Strength Index (RSI)	45.58
Average Volume (20 Days)	17,012,868

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:600594 had revenue of CNY 1.91 billion and -234.63 million in losses. Loss per share was -0.30.

Revenue	1.91B
Gross Profit	1.13B
Operating Income	-189.47M
Pretax Income	-251.77M
Net Income	-234.63M
EBITDA	-11.36M
EBIT	-189.47M
Loss Per Share	-0.30

Balance Sheet

The company has 593.70 million in cash and 866.11 million in debt, with a net cash position of -272.42 million or -0.35 per share.

Cash & Cash Equivalents	593.70M
Total Debt	866.11M
Net Cash	-272.42M
Net Cash Per Share	-0.35
Equity (Book Value)	2.52B
Book Value Per Share	3.06
Working Capital	761.57M

Cash Flow

In the last 12 months, operating cash flow was 90.87 million and capital expenditures -48.49 million, giving a free cash flow of 42.37 million.

Operating Cash Flow	90.87M
Capital Expenditures	-48.49M
Free Cash Flow	42.37M
FCF Per Share	0.05

Margins

Gross margin is 59.19%, with operating and profit margins of -9.94% and -12.30%.

Gross Margin	59.19%
Operating Margin	-9.94%
Pretax Margin	-13.20%
Profit Margin	-12.30%
EBITDA Margin	-0.60%
EBIT Margin	-9.94%
FCF Margin	2.22%

Dividends & Yields

SHA:600594 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.39%
Shareholder Yield	0.39%
Earnings Yield	-7.44%
FCF Yield	1.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 16, 2015. It was a forward split with a ratio of 2.

Last Split Date	Jul 16, 2015
Split Type	Forward
Split Ratio	2

Scores

SHA:600594 has an Altman Z-Score of 2.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.31
Piotroski F-Score	3